Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.230
-0.010 (-0.81%)
At close: Oct 29, 2026, 4:00 PM EDT
1.230
0.00 (0.00%)
Pre-market: Oct 30, 2026, 6:12 AM EDT

Dogwood Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-29.53-27.97-12.23-5.45-12.32-15.64
Net Income
-36.04-35.51-12.86-5.3-12.25-15.96
Earnings Per Share
-1.71-7.13-12.52-7.05-27.66-48.00
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.616.5214.853.327.0314.01
Total Debt
0.130.1615.59---
Net Cash (Debt)
9.486.36-0.743.327.0314.01
Net Cash Growth
-28.25%---52.82%-49.81%-52.99%
Net Cash Per Share
0.451.28-0.724.4215.8842.04

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.11-15.62-8.79-4.87-11.47-15.69
Free Cash Flow
-15.11-15.62-8.79-4.87-11.47-15.69
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.